I'm a Stock Trader

One stock just sat there. The rest of the book didn't.

While fourteen positions refused to move, three others quietly built leads worth paying attention to.
Scoreboard Update
EXPERIMENT UPDATE — Day 57 System: +2.3% | SPY (same window): +0.0% | Alpha: +2.3% Win rate: 0% (0/18) Open positions: CRNX (day 49, +1.2%), CRNX (day 44, +0.9%), CRNX (day 43, +0.8%), CRNX (day 42, +0.6%), CRNX (day 41, +0.5%), CRNX (day 40, +0.4%), CRNX (day 37, +0.3%), CRNX (day 36, +0.2%), CRNX (day 35, +0.2%), CRNX (day 34, +0.3%), CRNX (day 33, +0.2%), CRNX (day 30, +0.2%), CRNX (day 26, +0.1%), CRNX (day 23, -0.0%), TEAM (day 14, +4.9%), TEAM (day 13, +3.9%), IOVA (day 12, +30.6%), RNG (day 9, +14.6%), TWST (day 8, +21.2%)

Today's market and our positions

SPY essentially did nothing today — closed at $773.58, up a rounding error of 0.01%. On a session like that, what you own matters far more than what the market does. And right now, what we own is a genuinely interesting split: fourteen positions in one stock that won't budge, and five positions moving quite a bit. The experiment is at Day 57. System return sits at +2.3% versus SPY's flat line over the same window. Win rate is still 0 of 18 closed trades — no exits today, so that number didn't move. The open book is where the real story is.

What our open trades are doing

Start with the elephant in the room: CRNX. Fourteen open positions from the Relative Strength Engine, entries ranging from $83.93 to $84.99, and today every single one of them printed exactly +0.00%. Not a typo — the stock simply refused to move. Alpha on these positions ranges from -1.41% to +0.58% depending on what SPY did on each respective entry day. None of them are in trouble. None of them are doing anything useful either. We're watching, not panicking. Then there's the other side of the book. IOVA is the position everyone should be looking at. Entered at $8.15 on day 12, it's now trading at $10.68 — that's +31.0% on the position, with +29.81% alpha versus SPY over the same stretch. Small stock, big move. The Relative Strength Engine caught it early, and the trend has held. TWST came in at $135.76 eight days ago and is now at $163.46, up 20.4% with +18.29% alpha. That's a clean trend-following move — exactly the kind the engine is built to find. RNG sits at $79.73 from a $69.55 entry nine days ago. Up 14.64%, with alpha of +12.99%. Holding well and not asking for attention. TEAM has two positions, both opened in the past two weeks. The day 14 entry is up 3.97%, the day 13 entry is up 2.95%. Both are outperforming SPY. Nothing dramatic — just steady, quiet progress.

Today's closed trades, post-mortem

No trades closed today, which means no post-mortems to run. The win rate holds at 0 of 18 — every closed trade this experiment has produced finished as a loss. That number still sits in the corner of the room, impossible to ignore. The open positions are currently doing the work of offsetting that history, and doing it well, but closed trades are closed trades. The moment something exits, we'll update the scorecard immediately.

What could change by tomorrow's open

The CRNX cluster is the main thing to keep an eye on. Fourteen positions, all frozen, most of them quietly losing ground to SPY day by day. If CRNX starts sliding, that's a lot of positions moving in the same direction at once — and there's no direct hedge against it in IOVA, TWST, or RNG. Those wins are real, but they're not insulation. On the momentum side, any one of those names could gap down overnight on earnings, a news event, or a sector rotation, and trim these gains faster than they built. SPY drifting sideways again tomorrow wouldn't hurt — but it wouldn't fix the CRNX drag, either.

What we're watching tomorrow

Tomorrow morning the engines scan fresh. The question worth sitting with tonight: does CRNX finally decide to do something — in either direction — or does it just park itself there for another day while the rest of the book keeps trying to carry it?

See how the system backtests →

How our rebuilt system performs against the S&P 500 in testing — year by year, with the honest caveats.


Keep exploring